Summary Of: ACE inhibitor

Encyclodia Page On: ACE inhibitor

These Are Links To Other Documents

| | Angiotensin-Converting Enzyme | pharmaceuticals | hypertension | congestive heart failure | cardiovascular | Congestive heart failure | Hypertension | ventricular | nephropathy | diabetes mellitus | morbidity | mortality | diuretics | thiazide | furosemide | hydrochlorothiazide | Renin-angiotensin system | hypotension | distal tubule | renal | sympathetic nerve | renin | angiotensinogen | angiotensin I | angiotensin II | pulmonary circulation | endothelium | citation needed | arteriolar | cardiac output | cardiac index | volume | natriuresis | sodium | urine | hypertension | efferent arterioles | kidney | glomeruli | Ventricular remodeling | ventricular hypertrophy | aldosterone | vasopressin | Epidemiological | diabetic nephropathy | citation needed | renal failure | adverse drug reactions | hypotension | cough | hyperkalemia | headache | dizziness | fatigue | nausea | bradykinin | angiotensin II receptor antagonists | captopril | scintigraphy | homeostatic | efferent arterioles | glomeruli | glomerular filtration rate | renal function | renal artery stenosis | NSAID | diuretic | hyperkalemia | angioedema | Captopril | Zofenopril | Enalapril | Ramipril | Quinapril | Perindopril | Lisinopril | Benazepril | Fosinopril | casein | whey | milk | cultured milk | tripeptides | probiotic | Lactobacillus helveticus | captopril | myocardial infarction | angioedema | Renal artery stenosis | Aortic valve stenosis | Hypovolaemia | dehydration | Haemodialysis | ADEC | Pregnancy category | black box | trimester | congenital malformations | cardiovascular | central nervous systems | hyperkalaemic | angiotensin II receptor antagonists | essential hypertension | heart failure | nephropathy | morbidity | ventricular remodeling | proteinuria | diabetic nephropathy | IgA nephropathy | ACE inhibitors drug design | plasma | John R. Vane | Bradykinin | Sérgio Henrique Ferreira | Bothrops jararaca | David Cushman | Miguel Ondetti | captopril | Food and Drug Administration | Angiotensin II receptor antagonist | Angiotensin Receptor Blockers: Drug discovery and development | Australian Medicines Handbook | ISBN 0-9757919-2-3 | v | d | renin-angiotensin | C09 | Alacepril | Benazepril | Captopril | Cilazapril | Delapril | Enalapril | Fosinopril | Imidapril | Lisinopril | Moexipril | Perindopril | Quinapril | Ramipril | Spirapril | Temocapril | Trandolapril | Zofenopril | Angiotensin II receptor antagonists | Azilsartan | Candesartan | Eprosartan | Irbesartan | Losartan | Olmesartan | Tasosartan | Telmisartan | Valsartan | Renin inhibitors | Aliskiren | Remikiren | v | d | Major drug groups | Gastrointestinal tract | metabolism | A | Antacids | H2 antagonists | Proton pump inhibitors | Antiemetics | Laxatives | Antidiarrhoeals | Antipropulsives | Anti-obesity drugs | Anti-diabetics | Vitamins | Dietary minerals | Blood | B | Antithrombotics | Anticoagulants | Antiplatelets | Thrombolytics | Antihemorrhagics | Cardiovascular system | C | antianginals | Cardiac glycosides | Antiarrhythmics | Cardiac stimulant | Antihypertensives | Diuretics | Vasodilators | Beta blockers | Calcium channel blockers | renin-angiotensin system | Angiotensin II receptor antagonists | Renin inhibitors | Antihyperlipidemics | Statins | Fibrates | Bile acid sequestrants | Skin | D | Emollients | Cicatrizant | Antipruritics | Antipsoriatic | Medicated dressings | Reproductive system | G | Hormonal contraception | Fertility agents | SERMs | Sex hormones | Endocrine system | H | Hypothalamic-pituitary hormones | Corticosteroids | Glucocorticoids | Mineralocorticoids | Sex hormones | Thyroid hormones | Antithyroid agent | Infections | J | P | Antibiotics | Antifungals | Antimycobacterial | Tuberculosis treatment | Leprostatic agent | Antivirals | Vaccines | Antiparasitic | Antiprotozoals | Anthelmintics | Malignant | L01-L02 | Anticancer agents | Antimetabolite | Alkylating | Spindle poison | Antineoplastic | Topoisomerase inhibitor | Immune | L03-L04 | Immunomodulators | Immunostimulators | Immunosuppressants | Muscles | bones | joints | M | Anabolic steroids | Anti-inflammatories | NSAID | Antirheumatics | Corticosteroids | Muscle relaxants | Bisphosphonate | Brain | nervous system | N | Anesthetics | General | Local | Analgesics | Antimigraines | Anticonvulsants | Mood stabilizers | Antiparkinson drug | Psycholeptic | Anxiolytics | Antipsychotics | Hypnotics | Sedatives | Psychoanaleptic | Antidepressants | Stimulants | Psychostimulants | Respiratory system | R | Decongestants | Bronchodilators | Cough medicine | H1 antagonists | Sensory organs | S | Ophthalmologicalss | Otologicals | Ophthalmological preparations | Otological preparations | V | Antidotes | Contrast media | Radiopharmaceuticals | Dressing | v | d | Pharmacology | enzyme inhibition | Competitive inhibition | Uncompetitive inhibition | Non-competitive inhibition | Suicide inhibition | Mixed inhibition | Oxidoreductase | Aromatase inhibitors | Lipoxygenase inhibitor | Monoamine oxidase inhibitors | COX-2 inhibitor | Xanthine oxidase inhibitor | Transferase | Integrase inhibitor | Protein kinase inhibitors | Reverse transcriptase inhibitors | COMT inhibitors | Hydrolase | Acetylcholinesterase inhibitors | Phosphodiesterase inhibitors | Protease inhibitors | Trypsin inhibitor | Histone deacetylase inhibitor | Dipeptidyl peptidase-4 inhibitors | Lyase | Carbonic anhydrase inhibitors | Dopa decarboxylase inhibitor | Categories | ACE inhibitors | Antihypertensive agents | All articles with unsourced statements | Articles with unsourced statements since October 2008 | Articles with unsourced statements since May 2008 |